Peking University Cancer Hospital & Institute

This study looks at how well a drug called Trop-2 ADC (sacituzumab govitecan) works for breast cancer patients whose cancer has spread to the brain. Researchers will track 100 patients from multiple hospitals to see if the drug shrinks brain tumors and how safe it is. The goal is…

This study tests a combination of chemotherapy drugs and an immunotherapy drug for a rare type of stomach cancer called hepatoid adenocarcinoma. The treatment is given before and after surgery to see if it can shrink the tumor and improve outcomes. The trial involves 30 participa…

This study tests a combination of three drugs (RC48, chemotherapy, and an immunotherapy) given before and after surgery for a rare stomach cancer called hepatoid adenocarcinoma. The goal is to see if this approach can completely eliminate the tumor before surgery and prevent it f…

This early-phase study tests whether adding a targeted radioactive drug ([225Ac]Ac-DOTATATE) to an immunotherapy (tislelizumab) can help control extensive-stage small cell lung cancer after initial treatment. About 24 adults whose tumors have a specific marker (SSTR) will receive…

This study is testing whether adding the drug adebrelimab to standard chemotherapy before surgery, and continuing it alone after surgery, can help people with a certain type of esophageal cancer. The goal is to see if this approach can eliminate or shrink the tumor more effective…

This study tests whether combining the immunotherapy drug camrelizumab with chemotherapy can shrink esophageal cancer enough to avoid surgery and preserve the organ. About 283 adults with resectable esophageal squamous cell cancer will receive the treatment before any surgery dec…

This early-phase study is testing a new imaging probe that targets a protein called CAIX, which is found in high levels in most clear cell kidney cancers. The goal is to see if this probe can help detect these tumors more accurately and non-invasively using PET scans. The study i…

This study tests a new type of PET scan that uses a radioactive tracer to see how well breast cancer patients respond to a targeted therapy called antibody-drug conjugate (ADC). The scan measures changes in tumor activity before and after treatment. Researchers aim to find out if…

This study tests a new PET scan that uses a special probe to find a protein called CLDN18.2 on solid tumors. The goal is to see if the scan can identify which patients might benefit from treatments that target this protein. About 15 adults with solid tumors will receive an inject…

This study tests a new radioactive tracer called [68Ga]N188 for PET scans to find a protein called nectin-4 in people with urothelial carcinoma, a type of bladder cancer. The goal is to see if this tracer can better detect tumors, especially in patients with advanced or recurring…

This study looks at whether a traditional Chinese herbal medicine, called modified Bufei decoction, can reduce common symptoms like cough, tiredness, and shortness of breath in people aged 65 and older who have had lung cancer surgery. About 174 participants will receive either t…

This study looks at people with early-stage lung cancer who had surgery and have no detectable tumor DNA in their blood. Half will get standard follow-up care, and the other half will have regular DNA tests and imaging instead of immediate extra treatment. The goal is to see if t…